Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Jan-23 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 394 | 578 | 671 | 842 | 1,012 | 1,004 | 1,015 | 1,289 | 1,454 | 1,417 | | 1,182 |
% Growth | NA | 47.0% | 16.0% | 25.6% | 20.2% | -0.8% | 1.1% | 26.9% | 12.8% | -2.6% | | |
| | | | | | | | | | | | |
Cost of Revenue | (319) | (453) | (504) | (670) | (805) | (782) | (851) | (1,138) | (1,302) | (1,214) | | (967) |
Gross Profit | 75 | 126 | 167 | 172 | 207 | 222 | 165 | 151 | 153 | 203 | | 215 |
% Revenue | 19.0% | 21.7% | 24.8% | 20.5% | 20.5% | 22.1% | 16.2% | 11.7% | 10.5% | 14.3% | | 18.2% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | (27) | (36) | (38) | (44) | (54) | (57) | (60) | | (56) |
Selling and Marketing | (17) | (24) | (39) | (46) | (55) | (58) | (27) | (37) | (28) | (34) | | (39) |
General and Admin | (26) | (42) | (57) | (30) | (30) | (30) | (34) | (53) | (62) | (46) | | (48) |
Other Inc / (Exp) | (2) | (6) | (3) | (4) | 1 | (5) | (1) | 7 | (14) | (13) | | (4) |
Total Operating Exp | (45) | (72) | (100) | (107) | (121) | (131) | (106) | (137) | (160) | (154) | | (148) |
| | | | | | | | | | | | |
Operating Income | 30 | 54 | 66 | 65 | 87 | 91 | 59 | 13 | (8) | 49 | | 67 |
% Revenue | 7.7% | 9.3% | 9.9% | 7.7% | 8.6% | 9.1% | 5.8% | 1.0% | -0.5% | 3.5% | | 5.7% |
| | | | | | | | | | | | |
Interest Expense | 0 | 0 | 0 | 2 | 2 | 4 | 4 | 8 | (4) | 2 | | 7 |
Pre-tax Income | 30 | 54 | 66 | 67 | 88 | 95 | 62 | 22 | (11) | 52 | | 74 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (5) | (10) | (12) | (9) | (13) | (13) | (3) | 3 | 9 | (5) | | (8) |
Net Income to Company | 25 | 43 | 54 | 58 | 76 | 83 | 59 | 25 | (3) | 46 | | 66 |
% Margin | 6.4% | 7.5% | 8.1% | 6.8% | 7.5% | 8.2% | 5.8% | 2.0% | -0.2% | 3.3% | | 5.6% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | (0) | 0 | (0) | 1 | (1) | 4 | | 4 |
Net Income to Stockholders | 25 | 44 | 55 | 58 | 76 | 83 | 59 | 26 | (3) | 50 | | 70 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 25 | 44 | 55 | 58 | 76 | 83 | 59 | 26 | (3) | 50 | | 70 |
% Margin | 6.4% | 7.6% | 8.2% | 6.8% | 7.5% | 8.2% | 5.8% | 2.0% | -0.2% | 3.5% | | 5.9% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.42 | 0.57 | 0.50 | 0.47 | 0.59 | 0.62 | 0.41 | 0.15 | (0.02) | 0.28 | | 0.40 |
Diluted EPS (Continuing Ops) | 0.42 | 0.57 | 0.50 | 0.47 | 0.59 | 0.62 | 0.41 | 0.15 | (0.02) | 0.28 | | 0.40 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 60.12 | 76.92 | 109.83 | 122.70 | 127.97 | 133.37 | 143.60 | 172.90 | 168.13 | 179.04 | | 177.94 |
WA Diluted Shares Out. | 60.12 | 76.92 | 109.83 | 122.70 | 127.97 | 133.37 | 143.60 | 172.90 | 168.13 | 179.04 | | 177.94 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 30 | 54 | 66 | 67 | 88 | 95 | 62 | 22 | (11) | 52 | | 74 |
Addback: Net Interest Expense | 0 | (0) | 0 | (2) | (2) | (4) | (4) | (8) | 4 | (2) | | (7) |
Addback: Other Non Operating Expenses, Total | 0 | (0) | (3) | 4 | 0 | 1 | 2 | 3 | 2 | 3 | | 2 |
Addback: Depreciation & Amortization | 7 | 8 | 11 | 0 | 0 | 22 | 26 | 37 | 52 | 48 | | 45 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | (2) | (1) | (0) | (0) | | (3) |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | 2 | | (0) |
Addback: Asset Writedown | 1 | 4 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 11 | | 8 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | (4) | (6) | (1) | (4) | (15) | 3 | (6) | | (5) |
Adjusted EBITDA | 38 | 65 | 77 | 65 | 81 | 113 | 80 | 39 | 50 | 107 | | 114 |
% Margin | 9.6% | 11.2% | 11.5% | 7.7% | 8.0% | 11.3% | 7.9% | 3.0% | 3.5% | 7.5% | | 9.6% |
| | | | | | | | | | | | |
Adjusted EBIT | 31 | 57 | 66 | 65 | 81 | 91 | 55 | 2 | (2) | 58 | | 68 |
% Margin | 7.9% | 9.9% | 9.8% | 7.7% | 8.0% | 9.0% | 5.4% | 0.1% | -0.1% | 4.1% | | 5.8% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 25 | 43 | 54 | 58 | 76 | 83 | 59 | 25 | (3) | 46 | | 66 |
Addback: Unusual Items | 1 | 4 | 2 | (4) | (6) | (1) | (6) | (15) | 4 | 6 | | (1) |
Less: Tax Benefit of Unusual Items (26%) | (0) | (1) | (1) | 1 | 1 | 0 | 2 | 4 | (1) | (1) | | 0 |
Adjusted Net Income | 26 | 46 | 56 | 55 | 71 | 82 | 54 | 14 | 0 | 51 | | 65 |
% Margin | 6.5% | 8.0% | 8.4% | 6.5% | 7.1% | 8.2% | 5.4% | 1.1% | 0.0% | 3.6% | | 5.5% |